Free Trial

ResMed (RMD) Insider Trading & Ownership

ResMed logo
$219.85 -2.77 (-1.24%)
Closing price 03/28/2025 03:59 PM Eastern
Extended Trading
$219.87 +0.02 (+0.01%)
As of 03/28/2025 05:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ResMed (NYSE:RMD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.71%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
8
Amount Of
Insider Selling
(Last 12 Months)
$49.73 M
Get RMD Insider Trade Alerts

Want to know when executives and insiders are buying or selling ResMed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RMD Insider Buying and Selling by Quarter

Remove Ads

ResMed Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/10/2025Kaushik GhoshalInsiderSell9,745$239.31$2,332,075.95  
3/7/2025Michael J FarrellCEOSell8,009$229.20$1,835,662.80  
3/5/2025Peter C FarrellDirectorSell2,000$227.71$455,420.00  
3/3/2025Kaushik GhoshalInsiderSell9,113$235.40$2,145,200.20  
2/7/2025Michael J FarrellCEOSell8,009$236.77$1,896,290.93  
2/5/2025Peter C FarrellDirectorSell2,000$242.11$484,220.00  
2/3/2025Michael J RiderGeneral CounselSell64$242.42$15,514.88  
1/13/2025Robert Bresnahan, Jr.U.S. Congress Member (R-PA)Sell$230.55$1,001 - $15,000
12/4/2024Peter C FarrellDirectorSell2,000$245.65$491,300.00  
12/2/2024Michael J RiderGeneral CounselSell74$248.91$18,419.34  
11/22/2024Justin LeongInsiderSell6,160$243.09$1,497,434.40  
11/12/2024Witte Jan DeDirectorSell796$248.81$198,052.76  
11/6/2024Peter C FarrellDirectorSell2,000$248.74$497,480.00  
11/1/2024Michael J RiderGeneral CounselSell69$242.00$16,698.00  
10/11/2024Kaushik GhoshalInsiderSell4,260$238.48$1,015,924.80  
10/8/2024Brett SandercockCFOSell1,000$233.47$233,470.00  
10/7/2024Michael J FarrellCEOSell14,683$231.91$3,405,134.53  
10/7/2024Michael J FarrellCEOSell14,683$231.91$3,405,134.53  
10/2/2024Peter C FarrellDirectorSell2,000$237.20$474,400.00  
9/12/2024Kaushik GhoshalInsiderSell5,000$252.56$1,262,800.00  
9/9/2024Brett SandercockCFOSell1,000$246.42$246,420.00  
9/9/2024Michael J FarrellCEOSell14,683$248.38$3,646,963.54  
9/4/2024Peter C FarrellDirectorSell2,000$239.90$479,800.00  
8/20/2024Michael J RiderGeneral CounselSell882$231.00$203,742.00  
8/8/2024Brett SandercockCFOSell1,000$212.16$212,160.00  
8/7/2024Michael J FarrellCEOSell14,683$214.25$3,145,832.75  
8/5/2024Justin LeongInsiderSell48,000$217.07$10,419,360.00  
7/8/2024Brett SandercockCFOSell1,000$194.35$194,350.00  
7/8/2024Michael J FarrellCEOSell14,683$192.97$2,833,378.51  
6/10/2024Brett SandercockCFOSell1,000$209.81$209,810.00  
6/7/2024Michael J FarrellCEOSell14,683$211.66$3,107,803.78  
5/15/2024Witte Jan DeDirectorSell360$218.29$78,584.40  
5/7/2024Michael J FarrellCEOSell14,683$216.50$3,178,869.50  
5/3/2024Tommy TubervilleU.S. Congress Member (R-AL)Sell$216.98$1,001 - $15,000
4/29/2024Karen DrexlerDirectorSell425$214.92$91,341.00  
(Data available from 1/1/2013 forward)

RMD Insider Trading Activity - Frequently Asked Questions

0.71% of ResMed stock is owned by insiders. Learn more on RMD's insider holdings.

The following insiders have sold RMD shares in the last 24 months: Brett Sandercock ($2,349,073.30), David Pendarvis ($1,013,490.00), Justin Leong ($11,916,794.40), Karen Drexler ($91,341.00), Kaushik Ghoshal ($7,555,650.95), Michael J Farrell ($35,066,090.99), Michael J Rider ($321,870.97), Peter C Farrell ($4,880,007.10), Robert Andrew Douglas ($1,615,500.00), and Witte Jan De ($276,637.16).

Insiders have sold a total of 299,392 ResMed shares in the last 24 months for a total of $65,086,455.87 sold.

Robert Bresnahan, Jr. (R-PA) and Tommy Tuberville (R-AL) have sold shares of ResMed in the last year totaling $16,000.

ResMed Key Executives



This page (NYSE:RMD) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners